Selected research
Market Structure
Global Digital Endocrine Disease Management Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Digital Endocrine Disease Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Digital Endocrine Disease Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Digital Endocrine Disease Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Digital Endocrine Disease Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Digital Endocrine Disease Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Digital Endocrine Disease Management include Abbott Diabetes Care, Dexcom Inc, Vida Health, Welldoc, Lark Health, Roche Diabetes Care, Oviva AG, Kaia Health and CureApp Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Digital Endocrine Disease Management market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Digital Endocrine Disease Management and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Digital Endocrine Disease Management revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Digital Endocrine Disease Management market size, projected growth trends, production technologies, key applications, and end-use industries.
Digital Endocrine Disease Management Segment by Company
Abbott Diabetes Care
Dexcom Inc
Vida Health
Welldoc
Lark Health
Roche Diabetes Care
Oviva AG
Kaia Health
CureApp Inc
Welby Inc
Ubie Inc
TeleMed2U
Twin Health
eddii-Care
DocVilla
Novo Nordisk Digital Health
Shangyi Technology
JD Health
Alibaba Health
Teladoc Health
Omada Health
Virta Health
Digital Endocrine Disease Management Segment by Type
Diabetes Management
Thyroid Disease Management
Obesity and Metabolic Disorder Management
PCOS Management
Osteoporosis Management
Others
Digital Endocrine Disease Management Segment by Application
Consumer Health
Chronic Disease Management
Hospital Digital Care
Employer Wellness
Others
Digital Endocrine Disease Management Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Endocrine Disease Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digital Endocrine Disease Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Endocrine Disease Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Digital Endocrine Disease Management in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Digital Endocrine Disease Management industry.
Chapter 3: Detailed analysis of Digital Endocrine Disease Management companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digital Endocrine Disease Managementrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
List of Tables
Table 1. Global Digital Endocrine Disease Management Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032
Table 2. Key Players of Diabetes Management
Table 3. Key Players of Thyroid Disease Management
Table 4. Key Players of Obesity and Metabolic Disorder Management
Table 3. Key Players of PCOS Management
Table 4. Key Players of Osteoporosis Management
Table 5. Key Players of Others
Table 6. Global Digital Endocrine Disease Management Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032
Table 7. Key Players of Consumer Health
Table 8. Key Players of Chronic Disease Management
Table 9. Key Players of Hospital Digital Care
Table 10. Key Players of Employer Wellness
Table 11. Key Players of Others
Table 12. Global Digital Endocrine Disease Management Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032
Table 13. Global Digital Endocrine Disease Management Market Size by Region (2021-2026) & (US$ Million)
Table 14. Global Digital Endocrine Disease Management Market Share by Region (2021-2026)
Table 15. Global Digital Endocrine Disease Management Market Size by Region (2027-2032) & (US$ Million)
Table 16. Global Digital Endocrine Disease Management Market Share by Region (2027-2032)
Table 17. Digital Endocrine Disease Management Industry Trends
Table 18. Digital Endocrine Disease Management Industry Drivers
Table 19. Digital Endocrine Disease Management Industry Opportunities and Challenges
Table 20. Digital Endocrine Disease Management Industry Restraints
Table 21. Global Digital Endocrine Disease Management Revenue by Company (US$ Million) & (2021-2026)
Table 22. Global Digital Endocrine Disease Management Revenue Market Share by Company (2021-2026)
Table 23. Global Digital Endocrine Disease Management Players Revenue Ranking, 2024 VS 2025 VS 2026
Table 24. Global Digital Endocrine Disease Management Key Company Head Office and Area Served
Table 25. Global Digital Endocrine Disease Management Company, Product Type & Application
Table 26. Global Digital Endocrine Disease Management Company Establishment Date
Table 27. Global Company Market Concentration Ratio (CR5 and HHI)
Table 28. Global Digital Endocrine Disease Management by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 29. Global Digital Endocrine Disease Management Market Size by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 30. Global Digital Endocrine Disease Management Market Size by Type (2021-2026) & (US$ Million)
Table 31. Global Digital Endocrine Disease Management Market Size by Type (2027-2032) & (US$ Million)
Table 32. Global Digital Endocrine Disease Management Revenue Market Share by Type (2021-2026)
Table 33. Global Digital Endocrine Disease Management Revenue Market Share by Type (2027-2032)
Table 34. Global Digital Endocrine Disease Management Market Size by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 35. Global Digital Endocrine Disease Management Market Size by Application (2021-2026) & (US$ Million)
Table 36. Global Digital Endocrine Disease Management Market Size by Application (2027-2032) & (US$ Million)
Table 37. Global Digital Endocrine Disease Management Revenue Market Share by Application (2021-2026)
Table 38. Global Digital Endocrine Disease Management Revenue Market Share by Application (2027-2032)
Table 39. Abbott Diabetes Care Company Information
Table 40. Abbott Diabetes Care Business Overview
Table 41. Abbott Diabetes Care Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 42. Abbott Diabetes Care Digital Endocrine Disease Management Product Portfolio
Table 43. Abbott Diabetes Care Recent Development
Table 44. Dexcom Inc Company Information
Table 45. Dexcom Inc Business Overview
Table 46. Dexcom Inc Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 47. Dexcom Inc Digital Endocrine Disease Management Product Portfolio
Table 48. Dexcom Inc Recent Development
Table 49. Vida Health Company Information
Table 50. Vida Health Business Overview
Table 51. Vida Health Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 52. Vida Health Digital Endocrine Disease Management Product Portfolio
Table 53. Vida Health Recent Development
Table 54. Welldoc Company Information
Table 55. Welldoc Business Overview
Table 56. Welldoc Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 57. Welldoc Digital Endocrine Disease Management Product Portfolio
Table 58. Welldoc Recent Development
Table 59. Lark Health Company Information
Table 60. Lark Health Business Overview
Table 61. Lark Health Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 62. Lark Health Digital Endocrine Disease Management Product Portfolio
Table 63. Lark Health Recent Development
Table 64. Roche Diabetes Care Company Information
Table 65. Roche Diabetes Care Business Overview
Table 66. Roche Diabetes Care Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 67. Roche Diabetes Care Digital Endocrine Disease Management Product Portfolio
Table 68. Roche Diabetes Care Recent Development
Table 69. Oviva AG Company Information
Table 70. Oviva AG Business Overview
Table 71. Oviva AG Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 72. Oviva AG Digital Endocrine Disease Management Product Portfolio
Table 73. Oviva AG Recent Development
Table 74. Kaia Health Company Information
Table 75. Kaia Health Business Overview
Table 76. Kaia Health Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 77. Kaia Health Digital Endocrine Disease Management Product Portfolio
Table 78. Kaia Health Recent Development
Table 79. CureApp Inc Company Information
Table 80. CureApp Inc Business Overview
Table 81. CureApp Inc Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 82. CureApp Inc Digital Endocrine Disease Management Product Portfolio
Table 83. CureApp Inc Recent Development
Table 84. Welby Inc Company Information
Table 85. Welby Inc Business Overview
Table 86. Welby Inc Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 87. Welby Inc Digital Endocrine Disease Management Product Portfolio
Table 88. Welby Inc Recent Development
Table 89. Ubie Inc Company Information
Table 90. Ubie Inc Business Overview
Table 91. Ubie Inc Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 92. Ubie Inc Digital Endocrine Disease Management Product Portfolio
Table 93. Ubie Inc Recent Development
Table 94. TeleMed2U Company Information
Table 95. TeleMed2U Business Overview
Table 96. TeleMed2U Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 97. TeleMed2U Digital Endocrine Disease Management Product Portfolio
Table 98. TeleMed2U Recent Development
Table 99. Twin Health Company Information
Table 100. Twin Health Business Overview
Table 101. Twin Health Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 102. Twin Health Digital Endocrine Disease Management Product Portfolio
Table 103. Twin Health Recent Development
Table 104. eddii-Care Company Information
Table 105. eddii-Care Business Overview
Table 106. eddii-Care Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 107. eddii-Care Digital Endocrine Disease Management Product Portfolio
Table 108. eddii-Care Recent Development
Table 109. DocVilla Company Information
Table 110. DocVilla Business Overview
Table 111. DocVilla Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 112. DocVilla Digital Endocrine Disease Management Product Portfolio
Table 113. DocVilla Recent Development
Table 114. Novo Nordisk Digital Health Company Information
Table 115. Novo Nordisk Digital Health Business Overview
Table 116. Novo Nordisk Digital Health Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 117. Novo Nordisk Digital Health Digital Endocrine Disease Management Product Portfolio
Table 118. Novo Nordisk Digital Health Recent Development
Table 119. Shangyi Technology Company Information
Table 120. Shangyi Technology Business Overview
Table 121. Shangyi Technology Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 122. Shangyi Technology Digital Endocrine Disease Management Product Portfolio
Table 123. Shangyi Technology Recent Development
Table 124. JD Health Company Information
Table 125. JD Health Business Overview
Table 126. JD Health Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 127. JD Health Digital Endocrine Disease Management Product Portfolio
Table 128. JD Health Recent Development
Table 129. Alibaba Health Company Information
Table 130. Alibaba Health Business Overview
Table 131. Alibaba Health Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 132. Alibaba Health Digital Endocrine Disease Management Product Portfolio
Table 133. Alibaba Health Recent Development
Table 134. Teladoc Health Company Information
Table 135. Teladoc Health Business Overview
Table 136. Teladoc Health Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 137. Teladoc Health Digital Endocrine Disease Management Product Portfolio
Table 138. Teladoc Health Recent Development
Table 139. Omada Health Company Information
Table 140. Omada Health Business Overview
Table 141. Omada Health Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 142. Omada Health Digital Endocrine Disease Management Product Portfolio
Table 143. Omada Health Recent Development
Table 144. Virta Health Company Information
Table 145. Virta Health Business Overview
Table 146. Virta Health Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 147. Virta Health Digital Endocrine Disease Management Product Portfolio
Table 148. Virta Health Recent Development
Table 149. North America Digital Endocrine Disease Management Market Size by Type (2021-2026) & (US$ Million)
Table 150. North America Digital Endocrine Disease Management Market Size by Type (2027-2032) & (US$ Million)
Table 151. North America Digital Endocrine Disease Management Market Size by Application (2021-2026) & (US$ Million)
Table 152. North America Digital Endocrine Disease Management Market Size by Application (2027-2032) & (US$ Million)
Table 153. North America Digital Endocrine Disease Management Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 154. North America Digital Endocrine Disease Management Market Size by Country (2021-2026)
Table 155. North America Digital Endocrine Disease Management Market Size by Country (2027-2032)
Table 156. Europe Digital Endocrine Disease Management Market Size by Type (2021-2026) & (US$ Million)
Table 157. Europe Digital Endocrine Disease Management Market Size by Type (2027-2032) & (US$ Million)
Table 158. Europe Digital Endocrine Disease Management Market Size by Application (2021-2026) & (US$ Million)
Table 159. Europe Digital Endocrine Disease Management Market Size by Application (2027-2032) & (US$ Million)
Table 160. Europe Digital Endocrine Disease Management Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 161. Europe Digital Endocrine Disease Management Market Size by Country (2021-2026)
Table 162. Europe Digital Endocrine Disease Management Market Size by Country (2027-2032)
Table 163. China Digital Endocrine Disease Management Market Size by Type (2021-2026) & (US$ Million)
Table 164. China Digital Endocrine Disease Management Market Size by Type (2027-2032) & (US$ Million)
Table 165. China Digital Endocrine Disease Management Market Size by Application (2021-2026) & (US$ Million)
Table 166. China Digital Endocrine Disease Management Market Size by Application (2027-2032) & (US$ Million)
Table 167. Asia Digital Endocrine Disease Management Market Size by Type (2021-2026) & (US$ Million)
Table 168. Asia Digital Endocrine Disease Management Market Size by Type (2027-2032) & (US$ Million)
Table 169. Asia Digital Endocrine Disease Management Market Size by Application (2021-2026) & (US$ Million)
Table 170. Asia Digital Endocrine Disease Management Market Size by Application (2027-2032) & (US$ Million)
Table 171. Asia Digital Endocrine Disease Management Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 172. Asia Digital Endocrine Disease Management Market Size by Country (2021-2026)
Table 173. Asia Digital Endocrine Disease Management Market Size by Country (2027-2032)
Table 174. South America, Middle East & Africa Digital Endocrine Disease Management Market Size by Type (2021-2026) & (US$ Million)
Table 175. South America, Middle East & Africa Digital Endocrine Disease Management Market Size by Type (2027-2032) & (US$ Million)
Table 176. South America, Middle East & Africa Digital Endocrine Disease Management Market Size by Application (2021-2026) & (US$ Million)
Table 177. South America, Middle East & Africa Digital Endocrine Disease Management Market Size by Application (2027-2032) & (US$ Million)
Table 178. South America, Middle East & Africa Digital Endocrine Disease Management Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 179. South America, Middle East & Africa Digital Endocrine Disease Management Market Size by Country (2021-2026)
Table 180. South America, Middle East & Africa Digital Endocrine Disease Management Market Size by Country (2027-2032)
Table 181. Research Programs/Design for This Report
Table 182. Authors List of This Report
Table 183. Secondary Sources
Table 184. Primary Sources
List of Figures
Figure 1. Digital Endocrine Disease Management Product Image
Figure 2. Global Digital Endocrine Disease Management Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million)
Figure 3. Global Digital Endocrine Disease Management Market Share by Type: 2025 VS 2032
Figure 4. Diabetes Management Image
Figure 5. Thyroid Disease Management Image
Figure 6. Obesity and Metabolic Disorder Management Image
Figure 7. PCOS Management Image
Figure 8. Osteoporosis Management Image
Figure 9. Others Image
Figure 10. Global Digital Endocrine Disease Management Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million)
Figure 11. Global Digital Endocrine Disease Management Market Share by Application: 2025 VS 2032
Figure 12. Consumer Health Image
Figure 13. Chronic Disease Management Image
Figure 14. Hospital Digital Care Image
Figure 15. Employer Wellness Image
Figure 16. Others Image
Figure 17. Global Digital Endocrine Disease Management Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 18. Global Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 19. Global Digital Endocrine Disease Management Market Share by Region: 2025 VS 2032
Figure 20. Years Considered
Figure 21. Global Digital Endocrine Disease Management Market Share by Players in 2025
Figure 22. Global Top 5 and 10 Digital Endocrine Disease Management Players Market Share by Revenue in 2025
Figure 23. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 24. Global Digital Endocrine Disease Management Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 25. Global Digital Endocrine Disease Management Revenue Market Share by Type (2021-2032)
Figure 26. Global Digital Endocrine Disease Management Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 27. Global Digital Endocrine Disease Management Revenue Market Share by Application (2021-2032)
Figure 28. North America Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 29. North America Digital Endocrine Disease Management Market Share by Type (2021-2032)
Figure 30. North America Digital Endocrine Disease Management Market Share by Application (2021-2032)
Figure 31. North America Digital Endocrine Disease Management Market Share by Country (2021-2032)
Figure 32. United States Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 33. Canada Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 34. Mexico Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 35. Europe Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 36. Europe Digital Endocrine Disease Management Market Share by Type (2021-2032)
Figure 37. Europe Digital Endocrine Disease Management Market Share by Application (2021-2032)
Figure 38. Europe Digital Endocrine Disease Management Market Share by Country (2021-2032)
Figure 39. Germany Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 40. France Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 41. U.K. Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 42. Italy Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 43. Russia Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 44. Nordic Countries Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 45. China Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 46. China Digital Endocrine Disease Management Market Share by Type (2021-2032)
Figure 47. China Digital Endocrine Disease Management Market Share by Application (2021-2032)
Figure 48. Asia Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 49. Asia Digital Endocrine Disease Management Market Share by Type (2021-2032)
Figure 50. Asia Digital Endocrine Disease Management Market Share by Application (2021-2032)
Figure 51. Asia Digital Endocrine Disease Management Market Share by Country (2021-2032)
Figure 52. Japan Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 53. South Korea Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 54. Taiwan Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 55. Southeast Asia Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 56. India Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 57. Australia Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 58. South America, Middle East & Africa Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 59. South America, Middle East & Africa Digital Endocrine Disease Management Market Share by Type (2021-2032)
Figure 60. South America, Middle East & Africa Digital Endocrine Disease Management Market Share by Application (2021-2032)
Figure 61. South America, Middle East & Africa Digital Endocrine Disease Management Market Share by Country (2021-2032)
Figure 62. Brazil Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 63. South Africa Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 64. Saudi Arabia Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 65. Turkey Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 66. Argentina Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 67. UAE Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 68. Egypt Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 69. Chile Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 70. Research Process
Figure 71. Key Executives Interviewed
Scope & coverage.
Types
- Diabetes Management
- Thyroid Disease Management
- Obesity and Metabolic Disorder Management
- PCOS Management
- Osteoporosis Management
- Others
Applications
- Consumer Health
- Chronic Disease Management
- Hospital Digital Care
- Employer Wellness
- Others
Companies covered
- Abbott Diabetes Care
- Dexcom Inc
- Vida Health
- Welldoc
- Lark Health
- Roche Diabetes Care
- Oviva AG
- Kaia Health
- CureApp Inc
- Welby Inc
- Ubie Inc
- TeleMed2U
- Twin Health
- eddii-Care
- DocVilla
- Novo Nordisk Digital Health
- Shangyi Technology
- JD Health
- Alibaba Health
- Teladoc Health
- Omada Health
- Virta Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Digital Endocrine Disease Management Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Diabetes Management
- 1.2.3 Thyroid Disease Management
- 1.2.4 Obesity and Metabolic Disorder Management
- 1.2.5 PCOS Management
- 1.2.6 Osteoporosis Management
- 1.2.7 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Digital Endocrine Disease Management Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Consumer Health
- 1.3.3 Chronic Disease Management
- 1.3.4 Hospital Digital Care
- 1.3.5 Employer Wellness
- 1.3.6 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Digital Endocrine Disease Management Growth Trends by Region
- 1.5.1 Global Digital Endocrine Disease Management Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Digital Endocrine Disease Management Market Size by Region (2021-2026)
- 1.5.3 Digital Endocrine Disease Management Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Digital Endocrine Disease Management Market Dynamics
- 2.1 Digital Endocrine Disease Management Industry Trends
- 2.2 Digital Endocrine Disease Management Industry Drivers
- 2.3 Digital Endocrine Disease Management Industry Opportunities and Challenges
- 2.4 Digital Endocrine Disease Management Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Digital Endocrine Disease Management Revenue by Company (2021-2026)
- 3.2 Global Digital Endocrine Disease Management Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Digital Endocrine Disease Management Key Company Head office and Area Served
- 3.4 Global Digital Endocrine Disease Management Company, Product Type & Application
- 3.5 Global Digital Endocrine Disease Management Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Digital Endocrine Disease Management Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Digital Endocrine Disease Management Players Market Share by Revenue in 2025
- 3.6.3 2025 Digital Endocrine Disease Management Tier 1, Tier 2, and Tier 3
4 Digital Endocrine Disease Management Market by Type
- 4.1 Global Digital Endocrine Disease Management Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Digital Endocrine Disease Management Market Size by Type (2021-2032)
- 4.3 Global Digital Endocrine Disease Management Market Size Share by Type (2021-2032)
5 Digital Endocrine Disease Management Market by Application
- 5.1 Global Digital Endocrine Disease Management Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Digital Endocrine Disease Management Market Size by Application (2021-2032)
- 5.3 Global Digital Endocrine Disease Management Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Abbott Diabetes Care
- 6.1.1 Abbott Diabetes Care Company Information
- 6.1.2 Abbott Diabetes Care Business Overview
- 6.1.3 Abbott Diabetes Care Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Abbott Diabetes Care Digital Endocrine Disease Management Product Portfolio
- 6.1.5 Abbott Diabetes Care Recent Developments
- 6.2 Dexcom Inc
- 6.2.1 Dexcom Inc Company Information
- 6.2.2 Dexcom Inc Business Overview
- 6.2.3 Dexcom Inc Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Dexcom Inc Digital Endocrine Disease Management Product Portfolio
- 6.2.5 Dexcom Inc Recent Developments
- 6.3 Vida Health
- 6.3.1 Vida Health Company Information
- 6.3.2 Vida Health Business Overview
- 6.3.3 Vida Health Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Vida Health Digital Endocrine Disease Management Product Portfolio
- 6.3.5 Vida Health Recent Developments
- 6.4 Welldoc
- 6.4.1 Welldoc Company Information
- 6.4.2 Welldoc Business Overview
- 6.4.3 Welldoc Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Welldoc Digital Endocrine Disease Management Product Portfolio
- 6.4.5 Welldoc Recent Developments
- 6.5 Lark Health
- 6.5.1 Lark Health Company Information
- 6.5.2 Lark Health Business Overview
- 6.5.3 Lark Health Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Lark Health Digital Endocrine Disease Management Product Portfolio
- 6.5.5 Lark Health Recent Developments
- 6.6 Roche Diabetes Care
- 6.6.1 Roche Diabetes Care Company Information
- 6.6.2 Roche Diabetes Care Business Overview
- 6.6.3 Roche Diabetes Care Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Roche Diabetes Care Digital Endocrine Disease Management Product Portfolio
- 6.6.5 Roche Diabetes Care Recent Developments
- 6.7 Oviva AG
- 6.7.1 Oviva AG Company Information
- 6.7.2 Oviva AG Business Overview
- 6.7.3 Oviva AG Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Oviva AG Digital Endocrine Disease Management Product Portfolio
- 6.7.5 Oviva AG Recent Developments
- 6.8 Kaia Health
- 6.8.1 Kaia Health Company Information
- 6.8.2 Kaia Health Business Overview
- 6.8.3 Kaia Health Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Kaia Health Digital Endocrine Disease Management Product Portfolio
- 6.8.5 Kaia Health Recent Developments
- 6.9 CureApp Inc
- 6.9.1 CureApp Inc Company Information
- 6.9.2 CureApp Inc Business Overview
- 6.9.3 CureApp Inc Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 CureApp Inc Digital Endocrine Disease Management Product Portfolio
- 6.9.5 CureApp Inc Recent Developments
- 6.10 Welby Inc
- 6.10.1 Welby Inc Company Information
- 6.10.2 Welby Inc Business Overview
- 6.10.3 Welby Inc Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Welby Inc Digital Endocrine Disease Management Product Portfolio
- 6.10.5 Welby Inc Recent Developments
- 6.11 Ubie Inc
- 6.11.1 Ubie Inc Company Information
- 6.11.2 Ubie Inc Business Overview
- 6.11.3 Ubie Inc Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Ubie Inc Digital Endocrine Disease Management Product Portfolio
- 6.11.5 Ubie Inc Recent Developments
- 6.12 TeleMed2U
- 6.12.1 TeleMed2U Company Information
- 6.12.2 TeleMed2U Business Overview
- 6.12.3 TeleMed2U Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 TeleMed2U Digital Endocrine Disease Management Product Portfolio
- 6.12.5 TeleMed2U Recent Developments
- 6.13 Twin Health
- 6.13.1 Twin Health Company Information
- 6.13.2 Twin Health Business Overview
- 6.13.3 Twin Health Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Twin Health Digital Endocrine Disease Management Product Portfolio
- 6.13.5 Twin Health Recent Developments
- 6.14 eddii-Care
- 6.14.1 eddii-Care Company Information
- 6.14.2 eddii-Care Business Overview
- 6.14.3 eddii-Care Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 eddii-Care Digital Endocrine Disease Management Product Portfolio
- 6.14.5 eddii-Care Recent Developments
- 6.15 DocVilla
- 6.15.1 DocVilla Company Information
- 6.15.2 DocVilla Business Overview
- 6.15.3 DocVilla Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 DocVilla Digital Endocrine Disease Management Product Portfolio
- 6.15.5 DocVilla Recent Developments
- 6.16 Novo Nordisk Digital Health
- 6.16.1 Novo Nordisk Digital Health Company Information
- 6.16.2 Novo Nordisk Digital Health Business Overview
- 6.16.3 Novo Nordisk Digital Health Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Novo Nordisk Digital Health Digital Endocrine Disease Management Product Portfolio
- 6.16.5 Novo Nordisk Digital Health Recent Developments
- 6.17 Shangyi Technology
- 6.17.1 Shangyi Technology Company Information
- 6.17.2 Shangyi Technology Business Overview
- 6.17.3 Shangyi Technology Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Shangyi Technology Digital Endocrine Disease Management Product Portfolio
- 6.17.5 Shangyi Technology Recent Developments
- 6.18 JD Health
- 6.18.1 JD Health Company Information
- 6.18.2 JD Health Business Overview
- 6.18.3 JD Health Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 JD Health Digital Endocrine Disease Management Product Portfolio
- 6.18.5 JD Health Recent Developments
- 6.19 Alibaba Health
- 6.19.1 Alibaba Health Company Information
- 6.19.2 Alibaba Health Business Overview
- 6.19.3 Alibaba Health Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 Alibaba Health Digital Endocrine Disease Management Product Portfolio
- 6.19.5 Alibaba Health Recent Developments
- 6.20 Teladoc Health
- 6.20.1 Teladoc Health Company Information
- 6.20.2 Teladoc Health Business Overview
- 6.20.3 Teladoc Health Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.20.4 Teladoc Health Digital Endocrine Disease Management Product Portfolio
- 6.20.5 Teladoc Health Recent Developments
- 6.21 Omada Health
- 6.21.1 Omada Health Company Information
- 6.21.2 Omada Health Business Overview
- 6.21.3 Omada Health Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.21.4 Omada Health Digital Endocrine Disease Management Product Portfolio
- 6.21.5 Omada Health Recent Developments
- 6.22 Virta Health
- 6.22.1 Virta Health Company Information
- 6.22.2 Virta Health Business Overview
- 6.22.3 Virta Health Digital Endocrine Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.22.4 Virta Health Digital Endocrine Disease Management Product Portfolio
- 6.22.5 Virta Health Recent Developments
7 North America
- 7.1 North America Digital Endocrine Disease Management Market Size (2021-2032)
- 7.2 North America Digital Endocrine Disease Management Market Size by Type
- 7.2.1 North America Digital Endocrine Disease Management Market Size by Type (2021-2026)
- 7.2.2 North America Digital Endocrine Disease Management Market Size by Type (2027-2032)
- 7.2.3 North America Digital Endocrine Disease Management Market Share by Type (2021-2032)
- 7.3 North America Digital Endocrine Disease Management Market Size by Application
- 7.3.1 North America Digital Endocrine Disease Management Market Size by Application (2021-2026)
- 7.3.2 North America Digital Endocrine Disease Management Market Size by Application (2027-2032)
- 7.3.3 North America Digital Endocrine Disease Management Market Share by Application (2021-2032)
- 7.4 North America Digital Endocrine Disease Management Market Size by Country
- 7.4.1 North America Digital Endocrine Disease Management Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Digital Endocrine Disease Management Market Size by Country (2021-2026)
- 7.4.3 North America Digital Endocrine Disease Management Market Size by Country (2027-2032)
- 7.4.4 North America Digital Endocrine Disease Management Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Digital Endocrine Disease Management Market Size (2021-2032)
- 8.2 Europe Digital Endocrine Disease Management Market Size by Type
- 8.2.1 Europe Digital Endocrine Disease Management Market Size by Type (2021-2026)
- 8.2.2 Europe Digital Endocrine Disease Management Market Size by Type (2027-2032)
- 8.2.3 Europe Digital Endocrine Disease Management Market Share by Type (2021-2032)
- 8.3 Europe Digital Endocrine Disease Management Market Size by Application
- 8.3.1 Europe Digital Endocrine Disease Management Market Size by Application (2021-2026)
- 8.3.2 Europe Digital Endocrine Disease Management Market Size by Application (2027-2032)
- 8.3.3 Europe Digital Endocrine Disease Management Market Share by Application (2021-2032)
- 8.4 Europe Digital Endocrine Disease Management Market Size by Country
- 8.4.1 Europe Digital Endocrine Disease Management Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Digital Endocrine Disease Management Market Size by Country (2021-2026)
- 8.4.3 Europe Digital Endocrine Disease Management Market Size by Country (2027-2032)
- 8.4.4 Europe Digital Endocrine Disease Management Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Digital Endocrine Disease Management Market Size (2021-2032)
- 9.2 China Digital Endocrine Disease Management Market Size by Type
- 9.2.1 China Digital Endocrine Disease Management Market Size by Type (2021-2026)
- 9.2.2 China Digital Endocrine Disease Management Market Size by Type (2027-2032)
- 9.2.3 China Digital Endocrine Disease Management Market Share by Type (2021-2032)
- 9.3 China Digital Endocrine Disease Management Market Size by Application
- 9.3.1 China Digital Endocrine Disease Management Market Size by Application (2021-2026)
- 9.3.2 China Digital Endocrine Disease Management Market Size by Application (2027-2032)
- 9.3.3 China Digital Endocrine Disease Management Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Digital Endocrine Disease Management Market Size (2021-2032)
- 10.2 Asia Digital Endocrine Disease Management Market Size by Type
- 10.2.1 Asia Digital Endocrine Disease Management Market Size by Type (2021-2026)
- 10.2.2 Asia Digital Endocrine Disease Management Market Size by Type (2027-2032)
- 10.2.3 Asia Digital Endocrine Disease Management Market Share by Type (2021-2032)
- 10.3 Asia Digital Endocrine Disease Management Market Size by Application
- 10.3.1 Asia Digital Endocrine Disease Management Market Size by Application (2021-2026)
- 10.3.2 Asia Digital Endocrine Disease Management Market Size by Application (2027-2032)
- 10.3.3 Asia Digital Endocrine Disease Management Market Share by Application (2021-2032)
- 10.4 Asia Digital Endocrine Disease Management Market Size by Country
- 10.4.1 Asia Digital Endocrine Disease Management Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Digital Endocrine Disease Management Market Size by Country (2021-2026)
- 10.4.3 Asia Digital Endocrine Disease Management Market Size by Country (2027-2032)
- 10.4.4 Asia Digital Endocrine Disease Management Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Digital Endocrine Disease Management Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Digital Endocrine Disease Management Market Size by Type
- 11.2.1 South America, Middle East & Africa Digital Endocrine Disease Management Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Digital Endocrine Disease Management Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Digital Endocrine Disease Management Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Digital Endocrine Disease Management Market Size by Application
- 11.3.1 South America, Middle East & Africa Digital Endocrine Disease Management Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Digital Endocrine Disease Management Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Digital Endocrine Disease Management Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Digital Endocrine Disease Management Market Size by Country
- 11.4.1 South America, Middle East & Africa Digital Endocrine Disease Management Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Digital Endocrine Disease Management Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Digital Endocrine Disease Management Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Digital Endocrine Disease Management Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst